RIFAMPICIN-RESISTANT TUBERCULOSIS

Clinical trials for RIFAMPICIN-RESISTANT TUBERCULOSIS explained in plain language.

Never miss a new study

Get alerted when new RIFAMPICIN-RESISTANT TUBERCULOSIS trials appear

Sign up with your email to follow new studies for RIFAMPICIN-RESISTANT TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet recruiting 2 Completed 1

New hope for hard-to-treat TB: experimental combo shows promise

Disease control Recruiting now

This study tests a new drug (JDB0131) combined with other medicines for people with a tough type of tuberculosis that doesn't respond to the usual antibiotic rifampin. About 60 adults and teens will receive either the new drug or an existing one (delamanid) for 8 weeks. The goal …

Matched conditions: RIFAMPICIN-RESISTANT TUBERCULOSIS

Phase: PHASE2 • Sponsor: WestVac Biopharma Co., Ltd. • Aim: Disease control

Last updated May 26, 2026 05:07 UTC

RIFAMPICIN-RESISTANT TUBERCULOSIS

Get alerted when new RIFAMPICIN-RESISTANT TUBERCULOSIS trials appear

New hope for hard-to-treat TB: experimental combo shows promise